148 related articles for article (PubMed ID: 11357521)
1. Bioassay of mannitol and caprolactam and assessment of response to diethylnitrosamine in heterozygous p53-deficient (+/-) and wild type (+/+) mice.
Iatropoulos MJ; Jeffrey AM; Schlüter G; Enzmann HG; Williams GM
Arch Toxicol; 2001 Mar; 75(1):52-8. PubMed ID: 11357521
[TBL] [Abstract][Full Text] [Related]
2. Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation, and initiation of carcinogenesis in rat liver display non-linearities and thresholds.
Williams GM; Iatropoulos MJ; Jeffrey AM; Luo FQ; Wang CX; Pittman B
Arch Toxicol; 1999 Sep; 73(7):394-402. PubMed ID: 10550482
[TBL] [Abstract][Full Text] [Related]
3. In ovo carcinogenicity assay (IOCA): evaluation of mannitol, caprolactam and nitrosoproline.
Brunnemann KD; Enzmann HG; Perrone CE; Iatropoulos MJ; Williams GM
Arch Toxicol; 2002 Oct; 76(10):606-12. PubMed ID: 12373457
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity and hepatotoxicity induced by inhaled bromodichloromethane in wild-type and p53-heterozygous mice.
Torti VR; Cobb AJ; Everitt JI; Marshall MW; Boorman GA; Butterworth BE
Toxicol Sci; 2001 Dec; 64(2):269-80. PubMed ID: 11719710
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.
Finnberg N; Stenius U; Högberg J
Cancer Lett; 2004 Apr; 207(2):149-55. PubMed ID: 15072823
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of hormonal carcinogenesis in the p53+/- hemizygous knockout mouse: studies with diethylstilbestrol.
Carmichael PL; Mills JJ; Campbell M; Basu M; Caldwell J
Toxicol Pathol; 2001; 29 Suppl():155-60. PubMed ID: 11695552
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice.
Delker DA; Yano BL; Gollapudi BB
Toxicol Sci; 2000 Jun; 55(2):361-9. PubMed ID: 10828268
[TBL] [Abstract][Full Text] [Related]
8. Induction of preneoplastic rat liver lesions with an attenuated p53 response by low doses of diethylnitrosamine.
Silins I; Stenius U; Högberg J
Arch Toxicol; 2004 Sep; 78(9):540-8. PubMed ID: 15340777
[TBL] [Abstract][Full Text] [Related]
9. Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine.
Okada N; Honda A; Kawabata M; Yajima N
Mutagenesis; 1997 May; 12(3):179-84. PubMed ID: 9175645
[TBL] [Abstract][Full Text] [Related]
10. Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice.
Puatanachokchai R; Kakuni M; Wanibuchi H; Kinoshita A; Kang JS; Salim EI; Morimura K; Tamano S; Merlino GT; Fukushima S
Asian Pac J Cancer Prev; 2006; 7(2):274-8. PubMed ID: 16839222
[TBL] [Abstract][Full Text] [Related]
11. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
[TBL] [Abstract][Full Text] [Related]
12. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Tamano S; Merlino GT; Ward JM
Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
[TBL] [Abstract][Full Text] [Related]
13. Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice.
Kushida M; Kamendulis LM; Peat TJ; Klaunig JE
Toxicol Pathol; 2011 Aug; 39(5):776-86. PubMed ID: 21628716
[TBL] [Abstract][Full Text] [Related]
14. Circadian disruption accelerates liver carcinogenesis in mice.
Filipski E; Subramanian P; Carrière J; Guettier C; Barbason H; Lévi F
Mutat Res; 2009; 680(1-2):95-105. PubMed ID: 19833225
[TBL] [Abstract][Full Text] [Related]
15. Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine.
Williams GM; Gebhardt R; Sirma H; Stenbäck F
Carcinogenesis; 1993 Oct; 14(10):2149-56. PubMed ID: 8106178
[TBL] [Abstract][Full Text] [Related]
16. Dose response of hepatocyte replication in rats following continuous exposure to diethylnitrosamine.
Deal FH; Richardson FC; Swenberg JA
Cancer Res; 1989 Dec; 49(24 Pt 1):6985-8. PubMed ID: 2582440
[TBL] [Abstract][Full Text] [Related]
17. Induction of micronuclei in wild-type and p53(+/-) transgenic mice by inhaled bromodichloromethane.
Torti VR; Cobb AJ; Wong VA; Butterworth BE
Mutat Res; 2002 Sep; 520(1-2):171-8. PubMed ID: 12297157
[TBL] [Abstract][Full Text] [Related]
18. Phenobarbital does not promote hepatic tumorigenesis in a twenty-six-week bioassay in p53 heterozygous mice.
Sagartz JE; Curtiss SW; Bunch RT; Davila JC; Morris DL; Alden CL
Toxicol Pathol; 1998; 26(4):492-500. PubMed ID: 9715508
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation and regulation of negative growth factors in mouse liver foci.
Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL
Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503
[TBL] [Abstract][Full Text] [Related]
20. Dietary iron overload inhibits carbon tetrachloride-induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation.
Wang GS; Eriksson LC; Xia L; Olsson J; Stål P
J Hepatol; 1999 Apr; 30(4):689-98. PubMed ID: 10207812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
